A carregar...

Biosafety studies of carrier cells infected with a replication-competent adenovirus introduced by IAI.3B promoter

The use of carrier cells infected with oncolytic viruses in cancer gene therapy is an attractive method because it can overcome viral immunogenicity and induce tumor immunity and significant antitumor activity. To enable human clinical trials of this treatment, acute and chronic toxicity tests must...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Ther Methods Clin Dev
Main Authors: Hamada, Katsuyuki, Shirakawa, Toshiro, Terao, Shuji, Gotoh, Akinobu, Tani, Kenzaburo, Huang, Wenlin
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4362384/
https://ncbi.nlm.nih.gov/pubmed/26015963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mtm.2014.19
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!